BOA1

Featured post

A Highly Pathogenic #Avian #H7N9 #Influenza Virus Isolated from A #Human Is Lethal in Some #Ferrets Infected via #Respiratory #Droplets (Cell Host Microbe, abstract)

Title : A Highly Pathogenic #Avian #H7N9 #Influenza Virus Isolated from A #Human Is Lethal in Some #Ferrets Infected via #Respiratory #Drop...

23 Oct 2017

#Influenza virus #characterisation, #Summary #Europe, September 2017 (@ECDC_EU, Oct. 23 ‘17)


Title: #Influenza virus #characterisation, #Summary #Europe, September 2017.

Subject: Human Influenza Viruses, antigenic and genetic characterization of recent isolates.

Source: European Centre for Disease Prevention and Control (ECDC), full page: (LINK).

Code: [     ]

_____

Influenza virus characterisation, Summary Europe, September 2017

_____

23 Oct 2017

Publication series: Influenza Virus Characterisation

Time period covered: 2016 – 2017

____

In the course of the 2016–17 influenza season, over 146 000 influenza detections across the WHO Europe Region have been reported. Influenza type A viruses have prevailed over type B with A(H3N2) viruses, greatly outnumbering A(H1N1)pdm09 and B/Yamagata-lineage detections (representing 73% of the type B viruses assigned to a lineage).


Executive summary

  • Since 1 February 2017, EU/EEA countries have shared 304 influenza positive specimens with collection dates after 31 January 2017.
  • Since the July 2017 report, 52 viruses have been characterised antigenically and 287 genetically.
  • The HA titres of many A(H3N2) viruses were so low that they could not be characterised antigenically by haemagglutination inhibition (HI) assay.
  • All seven A(H1N1)pdm09 viruses characterised antigenically were similar to the 2016–17 vaccine virus, A/California/7/2009, and showed good reactivity with antiserum raised against the subclade 6B.1 2017–18 vaccine virus, A/Michigan/45/2015.
  • Subclade 6B.1 viruses, defined by HA1 amino acid substitutions S162N and I216T, rapidly became dominant worldwide, and all (32) EU/EEA viruses with 2017 collection dates have fallen within this subclade.
  • Seventeen A(H3N2) viruses had sufficient HA titre for characterisation by HI assay.
  • Over half (13/17) were recognised well by antiserum raised against egg-propagated A/Hong Kong/4801/2014 (the current vaccine component).
  • Of 357 A(H3N2) viruses characterised genetically with collection dates in 2017, 124 (35%) were subclade 3C.2a, 228 (64%) were subclade 3C.2a1, and five (1%) were subclade 3C.3a.
  • Of the 13 B/Victoria-lineage viruses tested, all were antigenically similar to tissue culture-propagated surrogates of B/Brisbane/60/2008 (current vaccine component for the northern hemisphere 2017–18 season).
  • All 55 viruses characterised with collection dates in 2017, including viruses with deletion in HA1, fell in genetic clade 1A, as do recently collected viruses worldwide.
  • Of the 15 B/Yamagata viruses characterised antigenically, 14 reacted well with post-infection ferret antiserum raised against egg-propagated B/Phuket/3073/2013, the recommended vaccine virus for the northern hemisphere 2015–16 influenza season, for quadrivalent vaccines since 2016 and for trivalent vaccines in the southern hemisphere 2018 season. Of the 89 viruses characterised with 2017 collection dates, all fell in genetic clade 3.

____

Download: |-- Influenza virus characterisation, September 2017 - EN - [PDF-2.39 MB] –|

-

Keywords: ECDC; European Region; Updates; Seasonal Influenza.

------

Highly pathogenic #avian #influenza #H5N8, #Germany [infected #wildbirds] (#OIE, Oct. 23 ‘17)


Title: Highly pathogenic #avian #influenza #H5N8, #Germany [infected #wildbirds].

Subject: Avian Influenza, H5N8 subtype, wild birds epizootics in Germany.

Source: OIE, full page: (LINK).

Code: [     ]

_____

Highly pathogenic influenza A viruses (infection with) (non-poultry including wild birds) H5N8, Germany

____

Information received on 23/10/2017 from Dr. Karin Schwabenbauer, Ministerial Dirigentin and Chief Veterinary Officer , Directorate of Animal Health, Animal Welfare, Bundesministerium für Ernährung und Landwirtschaft (BMEL) , Bonn, Germany

  • Summary
    • Report type    Immediate notification (Final report)
    • Date of start of the event    18/10/2017
    • Date of confirmation of the event    18/10/2017
    • Report date    23/10/2017
    • Date submitted to OIE    23/10/2017
    • Date event resolved    18/10/2017
    • Reason for notification    Recurrence of a listed disease
    • Date of previous occurrence    09/2017
    • Manifestation of disease    Clinical disease
    • Causal agent    Highly pathogenic influenza A virus
    • Serotype    H5N8
    • Nature of diagnosis    Laboratory (basic), Laboratory (advanced), Necropsy
    • This event pertains to    the whole country
  • New outbreaks (1)
    • Outbreak 1 (17-015-00805)    - Osterwald, Grafschaft Bentheim, NIEDERSACHSEN
      • Date of start of the outbreak    18/10/2017
      • Outbreak status    Resolved (18/10/2017)
      • Epidemiological unit    Not applicable
      • Affected animals: Species    - Susceptible    - Cases    - Deaths    - Killed and disposed of – Slaughtered
        • Mallard:Anas platyrhynchos(Anatidae)  - … – 1    - 1    - 0    - 0
  • Summary of outbreaks   
    • Total outbreaks: 1
      • Total animals affected: Species    - Susceptible    - Cases    - Deaths    - Killed and disposed of – Slaughtered
        • Mallard:Anas platyrhynchos(Anatidae) – … – 1    - 1    - 0    - 0
    • Outbreak statistics: Species    - Apparent morbidity rate    - Apparent mortality rate    - Apparent case fatality rate    - Proportion susceptible animals lost*
      • Mallard:Anas platyrhynchos(Anatidae)    - **    - **    - 100.00%    - **
        • *Removed from the susceptible population through death, destruction and/or slaughter
        • **Not calculated because of missing information
  • Epidemiology
    • Source of the outbreak(s) or origin of infection   
      • Unknown or inconclusive
  • Control measures
    • Measures applied   
      • Vaccination prohibited
      • No treatment of affected animals
    • Measures to be applied   
      • No other measures
  • Diagnostic test results
    • Laboratory name and type:    Species    - Test    - Test date     - Result
      • Friedrich Loeffler Institute (FLI) (National laboratory)    - Mallard    - real-time PCR    - 18/10/2017    - Positive
  • Future Reporting
    • The event is resolved. No more reports will be submitted.


(...)

___

-

Keywords: OIE; Updates; Avian Influenza; H5N8 ; Wild Birds; Germany.

------

Highly pathogenic #avian #influenza #H5N6, #China [a #poultry #outbreak] (#OIE, Oct. 23 ‘17)


Title: Highly pathogenic #avian #influenza #H5N6, #China [a #poultry #outbreak].

Subject: Avian Influenza, H5N6 subtype, poultry epizootics in China.

Source: OIE, full page: (LINK).

Code: [     ]

_____

Highly pathogenic avian influenza H5N6, China (People's Rep. of)

____

Information received on 23/10/2017 from Dr Zhang Zhongqui, Director General , China Animal Disease Control Centre, Veterinary Bureau, Ministry of Agriculture, Beijing, China (People's Rep. of)

  • Summary
    • Report type    Follow-up report No. 1 (Final report)
    • Date of start of the event    10/08/2017
    • Date of confirmation of the event    18/08/2017
    • Report date    23/10/2017
    • Date submitted to OIE    23/10/2017
    • Date event resolved    23/10/2017
    • Reason for notification    Recurrence of a listed disease
    • Date of previous occurrence    30/08/2016
    • Manifestation of disease    Clinical disease
    • Causal agent    Highly pathogenic avian influenza virus
    • Serotype    H5N6
    • Nature of diagnosis    Clinical, Laboratory (basic), Laboratory (advanced)
    • This event pertains to    a defined zone within the country
  • Summary of outbreaks   
    • Total outbreaks: 1
      • Total animals affected: Species    - Susceptible    - Cases    - Deaths    - Killed and disposed of  - Slaughtered
        • Birds    - 45262    - 28650    - 15066    - 30196    - 0
      • Outbreak statistics: Species    - Apparent morbidity rate    - Apparent mortality rate    - Apparent case fatality rate    - Proportion susceptible animals lost*
        • Birds    - 63.30%    - 33.29%    - 52.59%    - 100.00%
          • *Removed from the susceptible population through death, destruction and/or slaughter
  • Epidemiology
    • Source of the outbreak(s) or origin of infection   
      • Unknown or inconclusive


(...)

___

-

Keywords: OIE; Updates; Avian Influenza; H5N6; Poultry; China.

------

Highly pathogenic #avian #influenza #H5N8, #Russia [a #poultry #outbreak] (#OIE, Oct. 23 ‘17)


Title: Highly pathogenic #avian #influenza #H5N8, #Russia [a #poultry #outbreak].

Subject: Avian Influenza, H5N8 subtype, poultry epizootics in Russia.

Source: OIE, full page: (LINK).

Code: [     ]

_____

Highly pathogenic avian influenza H5N8, Russia

____

Information received on 23/10/2017 from Dr Evgeny Nepoklonov, Vice-minister, Ministry of Agriculture, Ministry of Agriculture, Moscow, Russia

  • Summary
    • Report type    Follow-up report No. 22
    • Date of start of the event    02/12/2016
    • Date of confirmation of the event    06/12/2016
    • Report date    23/10/2017
    • Date submitted to OIE    23/10/2017
    • Reason for notification    Recurrence of a listed disease
    • Date of previous occurrence    07/11/2016
    • Manifestation of disease    Clinical disease
    • Causal agent    Highly pathogenic avian influenza virus
    • Serotype    H5N8
    • Nature of diagnosis    Laboratory (basic), Laboratory (advanced)
    • This event pertains to    a defined zone within the country
  • Summary of outbreaks   
    • Total outbreaks: 1
      • Total animals affected: Species    - Susceptible    - Cases    - Deaths    - Killed and disposed of – Slaughtered
        • Birds    - 1919    - 27    - 27  - … – …
      • Outbreak statistics: Species    - Apparent morbidity rate    - Apparent mortality rate    - Apparent case fatality rate    - Proportion susceptible animals lost*
        • Birds    - 1.41%    - 1.41%    - 100.00%    - **
          • *Removed from the susceptible population through death, destruction and/or slaughter
          • **Not calculated because of missing information
  • Epidemiology
    • Source of the outbreak(s) or origin of infection   
      • Unknown or inconclusive
  • Epidemiological comments   
    • The comparative analysis of the obtained nucleotide sequence of the H gene fragment revealed that the isolates belong to an Asian genetic lineage of highly pathogenic avian influenza (lineage A/Gs/Guangdong/96, Clade 2.3.4.4.).
    • Based on the H gene fragment the avian influenza A virus (H5) sequences were isolated in several RF Subjects in 2016-2017.
    • And the avian influenza A virus (H5) sequences were isolated in South-East Asia in 2013-2014, as well as in Europe and Iran in 2017.


(...)

___

-

Keywords: OIE; Updates; Avian Influenza; H5N8 ; Poultry; Russia.

------

Highly pathogenic #avian #influenza #H5N8, #Italy [two #poultry #outbreaks, infected #wildbirds] (#IZSVE, Oct. 23 ‘17)


Title: Highly pathogenic #avian #influenza #H5N8, #Italy [two #poultry #outbreaks, infected #wildbirds].

Subject: Avian Influenza, H5N8 subtype, poultry and wild birds epizootics in Italy.

Source: National Reference Laboratory for Avian Influenza, Padua, Italy, full page: (LINK).

Code: [     ]

_____

Highly pathogenic avian influenza (HPAI) in Italy

____

|-- Outbreaks | PDF (last update: 20/10/2017)  --|

|-- Maps | PDF (last update: 20/10/2017)  --|


Summary

  • On 13 October, samples from two mute swans (Cygnus olor) found in Verbano-Cusio-Ossola province (Piedmont region), were analysed at the National Reference Laboratory (NRL) for Avian Influenza and Newcastle Disease and resulted positive to Avian Influenza subtype H5.
    • On 17 October, NRL characterised the virus as Highly Pathogenic Avian Influenza (HPAI) virus subtype H5N8.
  • On 19 October, the National Reference Laboratory for Avian Influenza and Newcastle Disease confirmed as positive for Avian Influenza A virus subtype H5 a fattening turkeys farm in Brescia province (Lombardy region).
    • In close proximity to the outbreak, there is another fattening turkeys farm.
    • Due to proximity and lack of a clear separation, the two farms are being treated as a unique epidemiological unit.
    • The unit hosted 29.640 female turkeys, at the time of confirmation.
    • On 16 October evening, depressed sensorium was detected and, the next day, increased mortality was observed and reported to the Veterinary Services.
    • Epidemiological investigations revealed that the affected unit had risk contacts with the fattening turkeys farm in Brescia Province confirmed as positive for HPAI H5N8 on 9 October.
  • On 19 October, NRL confirmed as positive for Avian Influenza A virus subtype H5 another fattening turkeys farm located in Brescia province (Lombardy region).
    • The farm hosted 8.945 male turkeys, at the time of confirmation.
    • On 17 October evening, depressed sensorium was detected and, the next day, increased mortality was observed and reported to the Veterinary Services.
    • On 20 October, the virus isolated in the last two outbreaks were characterised by the NRL as Highly Pathogenic Avian Influenza (HPAI) virus subtype H5N8.

(…)

-

Keywords: Italy; Updates; Avian Influenza; H5N8; Poultry; Wild Birds.

-------

Highly pathogenic #avian #influenza #H5, #Bulgaria [two #poultry #outbreaks] (#OIE, Oct. 23 ‘17)


Title: Highly pathogenic #avian #influenza #H5, #Bulgaria [two #poultry #outbreaks].

Subject: Avian Influenza, H5N subtype, poultry and wild birds epizootics in .

Source: OIE, full page: (LINK).

Code: [     ]

_____

Highly pathogenic avian influenza H5, Bulgaria

____

Information received on 22/10/2017 from Dr Damyan Iliev, Chief Veterinary Officer & Deputy Executive Director, Bulgarian Food Safety Agency, Ministry of Agriculture and Food, Sofia, Bulgaria

  • Summary
    • Report type    Immediate notification
    • Date of start of the event    17/10/2017
    • Date of confirmation of the event    17/10/2017
    • Report date    22/10/2017
    • Date submitted to OIE    22/10/2017
    • Reason for notification    Recurrence of a listed disease
    • Date of previous occurrence    30/04/2017
    • Manifestation of disease    Clinical disease
    • Causal agent    Highly pathogenic avian influenza virus
    • Serotype    H5
    • Nature of diagnosis    Clinical, Laboratory (basic)
    • This event pertains to    a defined zone within the country
  • New outbreaks
    • Summary of outbreaks   
      • Total outbreaks: 2
        • Outbreak Location:
          • DOBRIC ( Stefanovo )
          • HASKOVO ( Uzundzhovo )
    • Total animals affected:    Species    - Susceptible    - Cases    - Deaths    - Killed and disposed of    - Slaughtered
      • Birds     - 10613     - 502     - 502     - 10111     - 0
    • Outbreak statistics:    Species    - Apparent morbidity rate    - Apparent mortality rate    - Apparent case fatality rate    - Proportion susceptible animals lost*
      • Birds    - 4.73%    - 4.73%    - 100.00%    - 100.00%
        • * Removed from the susceptible population through death, destruction and/or slaughter;
  • Epidemiology
    • Source of the outbreak(s) or origin of infection   
      • Unknown or inconclusive
  • Control measures
    • Measures applied   
      • Movement control inside the country
      • Surveillance outside containment and/or protection zone
      • Surveillance within containment and/or protection zone
      • Screening
      • Traceability
      • Quarantine
      • Official disposal of carcasses, by-products and waste
      • Stamping out
      • Control of wildlife reservoirs
      • Zoning
      • Disinfection
      • Vaccination prohibited
      • No treatment of affected animals
    • Measures to be applied   
      • No other measures
  • Diagnostic test results
    • Laboratory name and type:    National reference laboratory for avian influenza and Newcastle disease ( National laboratory )
      • Tests and results:    Species    - Test    - Test date    - Result
        • Birds    - real-time PCR    - 17/10/2017    - Positive
        • Birds    - real-time PCR    - 19/10/2017    - Positive
  • Future Reporting
    • The event is continuing. Weekly follow-up reports will be submitted.


(...)

___

-

Keywords: OIE; Updates; Avian Influenza; H5N8 ; Poultry; Bulgaria.

------

#Yemen – #Cholera Response – Daily #Epidemiological #Update, October 22 2017 (@WHO EMRO, edited)


Title: #Yemen – #Cholera Response – Daily #Epidemiological #Update, October 22 2017.

Subject: Acute Watery Diarrhea and Cholera Outbreak in Yemen, current situation.

Source: World Health Organization (WHO), Office for the Eastern Mediterranean Region, full PDF file: (LINK).

Code: [     ]

_____

Yemen – Cholera Response – Daily Epidemiological Update, October 22 2017

____


-

Keywords: Cholera; Yemen; WHO; Updates.

------

22 Oct 2017

#Zika #Virus #Research #References #Library–October 22 2017 #Update, Issue No. 88


Title: #Zika #Virus #Research #References #Library–October 22 2017 #Update, Issue No. 88.

Subject: Zika Virus Infection and related complications research, weekly references library update.

Source: AMEDEO, homepage: (LINK).

Code: [  R  ]

____

This Issue:

___

  1. KRITTANAWONG C.
    • Useful strategies for the emerging of Zika pandemic and its silent cardiovascular complications.
      • Eur J Prev Cardiol. 2017 Jan 1:2047487317737182. doi: 10.1177/2047487317737182.
  2. PITTS JD, Li PC, de Wispelaere M, Yang PL, et al.
    • Antiviral activity of fenretinide against Zika virus.
      • Antiviral Res. 2017 Oct 16. pii: S0166-3542(17)30613.
  3. BASILE K, Kok J, Dwyer DE.
    • Zika virus: what, where from and where to?
      • Pathology. 2017 Oct 16. pii: S0031-3025(17)30082.
  4. MESCI P, Macia A, LaRock CN, Tejwani L, et al.
    • Modeling neuro-immune interactions during Zika virus infection.
      • Hum Mol Genet. 2017 Oct 17. doi: 10.1093.
  5. ROUNDY CM, Azar SR, Brault AC, Ebel GD, et al.
    • Lack of evidence for Zika virus transmission by Culex mosquitoes.
      • Emerg Microbes Infect. 2017;6:e90.
  6. AYRES C, Guedes D, Paiva M, Donato M, et al.
    • Response to: 'Lack of evidence for Zika virus transmission by Culex mosquitoes'.
      • Emerg Microbes Infect. 2017;6:e91.
  7. KUROSAKI Y, Martins DBG, Kimura M, Catena ADS, et al.
    • Development and evaluation of a rapid molecular diagnostic test for Zika virus infection by reverse transcription loop-mediated isothermal amplification.
      • Sci Rep. 2017;7:13503.
  8. CAVALCANTI AL.
    • Challenges of Dental Care for Children with Microcephaly Carrying Zika Congenital Syndrome.
      • Contemp Clin Dent. 2017;8:345-346.
  9. MCQUADE L, Rao M, Miller R, Zhou W, et al.
    • Understanding Patterns of Socioeconomic and Demographic Factors Along With Health Services Provider Availability for Zika Outbreak in South Florida.
      • Disaster Med Public Health Prep. 2017 Oct 18:1-5. doi: 10.1017/dmp.2017.
  10. VARJAK M, Donald CL, Mottram TJ, Sreenu VB, et al.
    • Characterization of the Zika virus induced small RNA response in Aedes aegypti cells.
      • PLoS Negl Trop Dis. 2017;11:e0006010.
  11. JOOB B, Wiwanitkit V.
    • Congenital Toxoplasmosis, Cytomegalovirus, and Zika Virus Infections.
      • J Obstet Gynaecol Can. 2017 Oct 13. pii: S1701-2163(17)30807.
  12. WERNER H, Mehrjardi MZ, Araujo Junior E.
    • Congenital Toxoplasmosis, Cytomegalovirus, and Zika Virus Infections: Emphasis on the Role of Neuroimaging in Screening, Prognostication, and Follow-Up.
      • J Obstet Gynaecol Can. 2017 Oct 13. pii: S1701-2163(17)30869.
  13. MONSALVE DM, Pacheco Y, Acosta-Ampudia Y, Rodriguez Y, et al.
    • Zika virus and autoimmunity. One-step forward.
      • Autoimmun Rev. 2017 Oct 13. pii: S1568-9972(17)30258.
  14. LIN JJ, Chin TY, Chen CP, Chan HL, et al.
    • Zika virus: An emerging challenge for obstetrics and gynecology.
      • Taiwan J Obstet Gynecol. 2017;56:585-592.
  15. KOZAK RA, Majer A, Biondi MJ, Medina SJ, et al.
    • MicroRNA and mRNA Dysregulation in Astrocytes Infected with Zika Virus.
      • Viruses. 2017;9.
  16. LI C, Zhu X, Ji X, Quanquin N, et al.
    • Chloroquine, a FDA-approved Drug, Prevents Zika Virus Infection and its Associated Congenital Microcephaly in Mice.
      • EBioMedicine. 2017 Sep 28. pii: S2352-3964(17)30388.
  17. YI G, Xu X, Abraham S, Petersen S, et al.
    • A DNA Vaccine Protects Human Immune Cells against Zika Virus Infection in Humanized Mice.
      • EBioMedicine. 2017 Oct 6. pii: S2352-3964(17)30398.
  18. DUTTA S, Celestine MJ, Khanal S, Huddleston A, et al.
    • Coordination of different complexes to copper(II) and cobalt(III) metal centers enhances Zika virus and dengue virus loads in both arthropod cells and human keratinocytes.
      • Biochim Biophys Acta. 2017 Oct 10. pii: S0304-4165(17)30325.
  19. ASIF A, Manzoor S, Tuz-Zahra F, Saalim M, et al.
    • Zika Virus: Immune Evasion Mechanisms, Currently Available Therapeutic Regimens, and Vaccines.
      • Viral Immunol. 2017 Oct 13. doi: 10.1089/vim.2017.0046.
  20. SWARTWOUT BK, Zlotnick MG, Saver AE, McKenna CM, et al.
    • Zika Virus Persistently and Productively Infects Primary Adult Sensory Neurons In Vitro.
      • Pathogens. 2017;6.
  21. PANIZ MONDOLFI AE, Hernandez Perez M, Blohm G, Marquez M, et al.
    • Generalized pustular psoriasis triggered by Zika virus infection.
      • Clin Exp Dermatol. 2017 Oct 13. doi: 10.1111/ced.13294.
  22. ZAMANI M, Zamani V.
    • Sexual Transmission of Zika Virus: An Assessment of the Evidence.
      • Iran J Public Health. 2017;46:1305-1306.
  23. SCHUBERT B, de la Garza L, Mohr C, Walzer M, et al.
    • ImmunoNodes - graphical development of complex immunoinformatics workflows.
      • BMC Bioinformatics. 2017;18:242.
  24. BIASSOU NM.
    • New cerebral findings in infants with congenital Zika syndrome.
  25. PETRIBU NCL, Aragao MFV, van der Linden V, Parizel P, et al.
    • Follow-up brain imaging of 37 children with congenital Zika syndrome: case series study.
      • BMJ. 2017;359:j4188.
  26. TERZIAN ACB, Estofolete CF, Alves da Silva R, Vaz-Oliani DCM, et al.
    • Long-Term Viruria in Zika Virus-Infected Pregnant Women, Brazil, 2016.
      • Emerg Infect Dis. 2017;23:1891-1893.
  27. RYAN SJ, Carlson CJ, Stewart-Ibarra AM, Borbor-Cordova MJ, et al.
    • Outbreak of Zika Virus Infections, Dominica, 2016.
      • Emerg Infect Dis. 2017;23:1926-1927.
  28. DIRLIKOV E, Medina NA, Major CG, Munoz-Jordan JL, et al.
    • Acute Zika Virus Infection as a Risk Factor for Guillain-Barre Syndrome in Puerto Rico.
      • JAMA. 2017;318:1498-1500.
    • Virgin Islands' Zika Awareness.
  29. GARCIA-BUJALANCE S, Gutierrez-Arroyo A, De la Calle F, Diaz-Menendez M, et al.
    • Persistence and infectivity of Zika virus in semen after returning from endemic areas: Report of 5 cases.
      • J Clin Virol. 2017;96:110-115.
  30. NAG DK, Kramer LD.
    • Patchy DNA forms of the Zika virus RNA genome are generated following infection in mosquito cell cultures and in mosquitoes.
      • J Gen Virol. 2017 Oct 17. doi: 10.1099/jgv.0.000945.
  31. ADEBANJO T, Godfred-Cato S, Viens L, Fischer M, et al.
    • Update: Interim Guidance for the Diagnosis, Evaluation, and Management of Infants with Possible Congenital Zika Virus Infection - United States, October 2017.
      • MMWR Morb Mortal Wkly Rep. 2017;66:1089-1099.
  32. MORAIN SR, Wootton SH, Eppes C.
    • A Devastating Delay - Zika and the Implementation Gap.
      • N Engl J Med. 2017;377:1505-1507.
  33. RODO C, Suy A, Sulleiro E, Soriano-Arandes A, et al.
    • In utero negativization of Zika virus in a case with serious Central Nervous System abnormalities.
      • Clin Microbiol Infect. 2017 Oct 10. pii: S1198-743X(17)30539.
  34. SPITERI G, Sudre B, Septfons A, Beaute J, et al.
    • Surveillance of Zika virus infection in the EU/EEA, June 2015 to January 2017.
      • Euro Surveill. 2017;22.

-

Keywords: Research; Abstracts; Zika References Library.

------

#Yemen – #Cholera Response – Daily #Epidemiological #Update, October 21 2017 (@WHO EMRO, edited)


Title: #Yemen – #Cholera Response – Daily #Epidemiological #Update, October 21 2017.

Subject: Acute Watery Diarrhea and Cholera outbreak in Yemen, current situation.

Source: World Health Organization (WHO), Office for the Eastern Mediterranean Region, full PDF file: (LINK).

Code: [     ]

_____

Yemen – Cholera Response – Daily Epidemiological Update, October 21 2017

_____


-

Keywords: WHO; Updates; Cholera; Yemen.

------

21 Oct 2017

#Influenza and other #Respiratory #Viruses #Research #References #Library– October 21 2017 Issue


Title: #Influenza and other #Respiratory #Viruses #Research #References #Library– October 21 2017 Issue.

Subject: Human and Animal Influenza Viruses, other respiratory pathogens research, weekly references library update.

Source: AMEDEO, homepage: (LINK).

Code: [  R  ]

_____

This Issue:

___

  1. ANDREATOS N, Mylonakis E.
    • Triple therapy reduced mortality more than oseltamivir alone in patients admitted for severe influenza infection.
      • Ann Intern Med. 2017;167:JC41.
  2. GORDON NA, McGuire KL, Wallentine SK, Mohl GA, et al.
    • Divalent copper complexes as influenza A M2 inhibitors.
      • Antiviral Res. 2017;147:100-106.
  3. NIGWEKAR PV, Kumar A, Padbidri VV, Choudhury A, et al.
    • Safety of Russian-Backbone Trivalent, Live Attenuated Seasonal Influenza Vaccine in Healthy Subjects: Open-Label, Non-randomized Phase 4 Study.
      • Drug Saf. 2017 Oct 12. doi: 10.1007/s40264-017-0605.
  4. ZIVICH PN, Tatham L, Lung K, Tien J, et al.
    • Influenza vaccination status and outcomes among influenza-associated hospitalizations in Columbus, Ohio (2012-2015).
      • Epidemiol Infect. 2017 Oct 16:1-10. doi: 10.1017/S0950268817002163.
  5. HAN M, Rajput C, Hong JY, Lei J, et al.
    • The Innate Cytokines IL-25, IL-33, and TSLP Cooperate in the Induction of Type 2 Innate Lymphoid Cell Expansion and Mucous Metaplasia in Rhinovirus-Infected Immature Mice.
      • J Immunol. 2017;199:1308-1318.
  6. GAO S, Kang Y, Li S, Xiang B, et al.
    • Increasing genetic diversity of H5N6 avian influenza virus in china: a serious threat to persistence and dissemination in guangdong province.
      • J Infect. 2017 Oct 13. pii: S0163-4453(17)30316.
  7. SKOWRONSKI DM, Chambers C, De Serres G.
    • Selection bias in the assessment of frailty and its role in influenza vaccine effectiveness evaluation among elderly adults.
      • J Infect Dis. 2017 Oct 13. doi: 10.1093.
  8. OXMAN MN, Harbecke R, Koelle DM.
    • Clinical Usage of the Candidate Adjuvanted HZ/su Zoster Vaccine: re-vaccination of recipients of live attenuated zoster vaccine and co-administration with a seasonal influenza vaccine.
      • J Infect Dis. 2017 Sep 26. doi: 10.1093.
  9. SCHWARZ TF, Aggarwal N, Moeckesch B, Schenkenberger I, et al.
    • Immunogenicity and safety of an adjuvanted herpes zoster subunit vaccine co-administered with seasonal influenza vaccine in adults aged 50 years and older.
      • J Infect Dis. 2017 Sep 26. doi: 10.1093.
  10. BELONGIA E.
    • Beyond Antigenic Match: Moving Toward Greater Understanding of Influenza Vaccine Effectiveness.
      • J Infect Dis. 2017 Sep 27. doi: 10.1093.
  11. SKOWRONSKI DM, Chambers C, Sabaiduc S, De Serres G, et al.
    • Beyond antigenic match: possible agent-host and immuno-epidemiological influences on influenza vaccine effectiveness during the 2015-16 season in Canada.
      • J Infect Dis. 2017 Oct 4. doi: 10.1093.
  12. CHOI WS, Jeong JH, Kwon JJ, Ahn SJ, et al.
    • Screening for Neuraminidase Inhibitor Resistance Markers among Avian Influenza Viruses of the N4, N5, N6 and N8 Neuraminidase Subtypes.
      • J Virol. 2017 Oct 18. pii: JVI.01580-17. doi: 10.1128/JVI.01580.
  13. LIU H, Grantham ML, Pekosz A.
    • Mutations in the Influenza A virus M1 protein enhance virus budding to complement lethal mutations in the M2 cytoplasmic tail.
      • J Virol. 2017 Oct 18. pii: JVI.00858-17. doi: 10.1128/JVI.00858.
  14. SUTTON TC, Lamirande EW, Bock KW, Moore IN, et al.
    • In vitro neutralization is not predictive of prophylactic efficacy of broadly neutralizing monoclonal antibodies CR6261 and CR9114 against lethal H2 influenza virus challenge in mice.
      • J Virol. 2017 Oct 18. pii: JVI.01603-17. doi: 10.1128/JVI.01603.
  15. FRABUTT DA, Wang B, Riaz S, Schwartz RC, et al.
    • Innate sensing of influenza A virus hemagglutinin glycoproteins by the host endoplasmic reticulum (ER) stress pathway triggers a potent antiviral response via ER-associated protein degradation.
      • J Virol. 2017 Oct 18. pii: JVI.01690-17. doi: 10.1128/JVI.01690.
  16. BUFFIN S, Ikhelef N, Prudent J, Dubayle J, et al.
    • A latex agglutination assay to quantify the amount of hemagglutinin protein in adjuvanted low-dose influenza monovalent vaccines.
      • J Virol Methods. 2017;251:46-53.
  17. HOOS J, Peters RM, Tabatabai J, Grulich-Henn J, et al.
    • Reverse-transcription loop-mediated isothermal amplification for rapid detection of respiratory syncytial virus directly from nasopharyngeal swabs.
      • J Virol Methods. 2017;242:53-57.
  18. HU Z, Liu X, Jiao X, Liu X, et al.
    • Newcastle disease virus (NDV) recombinant expressing the hemagglutinin of H7N9 avian influenza virus protects chickens against NDV and highly pathogenic avian influenza A (H7N9) virus challenges.
      • Vaccine. 2017 Oct 14. pii: S0264-410X(17)31375.
  19. ORTIZ JR, Hombach J.
    • Announcing the publication of the WHO immunological basis for immunization series module on influenza vaccines.
      • Vaccine. 2017 Oct 14. pii: S0264-410X(17)31226.
  20. OLATUNBOSUN OD, Esterhuizen TM, Wiysonge CS.
    • A cross sectional survey to evaluate knowledge, attitudes and practices regarding seasonal influenza and influenza vaccination among diabetics in Pretoria, South Africa.
      • Vaccine. 2017 Oct 13. pii: S0264-410X(17)31370.
  21. MCELHANEY JE, Andrew MK, McNeil SA.
    • Estimating influenza vaccine effectiveness: Evolution of methods to better understand effects of confounding in older adults.
      • Vaccine. 2017;35:6269-6274.
  22. HO HJ, Chan YY, Ibrahim MAB, Wagle AA, et al.
    • A formative research-guided educational intervention to improve the knowledge and attitudes of seniors towards influenza and pneumococcal vaccinations.
      • Vaccine. 2017 Oct 11. pii: S0264-410X(17)31369.
  23. ANA-SOSA-BATIZ F, Johnston APR, Hogarth PM, Wines BD, et al.
    • Antibody-dependent phagocytosis (ADP) responses following trivalent inactivated influenza vaccination of younger and older adults.
      • Vaccine. 2017 Oct 10. pii: S0264-410X(17)31315.
  24. LION A, Richard M, Esnault E, Kut E, et al.
    • Productive replication of avian influenza viruses in chicken endothelial cells is determined by hemagglutinin cleavability and is related to innate immune escape.
      • Virology. 2017;513:29-42.
  25. BRADLEY JS, Blumer JL, Romero JR, Michaels MG, et al.
    • Intravenous Zanamivir in Hospitalized Patients With Influenza.
      • Pediatrics. 2017 Oct 19. pii: e20162727. doi: 10.1542/peds.2016-2727.

-

Keywords: Research; Abstracts; Influenza References Library.

------